Re-Vana Therapeutics

Biotechnology Research • Belfast, N. Ireland, United Kingdom • 21-50 Employees

Company overview

Headquarters	McClay Research Centre, 97 Lisburn Road, Belfast, Northern Ireland BT9 7BL, GB
Phone number	+4420152024
Websites	revanatx.com re-vana.com
NAICS	541714
Keywords	Drug Delivery, Polymers, AMD, Biologics, Ophthalmology, Macular Degeneration, Retina Specialist, Retinal Disease, Sustained Release, Drug Durability, Photo-Crosslinking, Reduced Patient Burden
Founded	2016
Employees	21-50
Socials

Key Contacts at Re-Vana Therapeutics

Michael J. O'Rourke

Ceo

Brian Mccaul

Non Executive Director

Anna Sumeray

Director Board Of Directors

James Murray

Non Executive Director

Jenna Hewitt

Director Of Program Management

Re-Vana Therapeutics Email Formats

Re-Vana Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@revanatx.com), used 50% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@revanatx.com	50%
{first name}.{last name}	john.doe@revanatx.com	50%

About Re-Vana Therapeutics

Re-Vana Therapeutics is a venture-backed, pioneering therapeutics and ocular drug delivery company developing innovative sustained-release biologics to treat serious retinal diseases. The company’s proprietary photo-crosslinked, biodegradable platform technologies, EyeLief®, EyeLief SD™ and OcuLief®, enable custom delivery of a wide range of therapeutic molecules. Numerous platform capabilities create a therapeutic continuum to expand treatment opportunities through both internal development and external, strategic collaborations. Re-Vana envisions a new industry standard for sustained delivery of biologics to the retina, creating transformative and differentiated treatments for physicians and significantly reducing patient treatment burden.

Re-Vana Therapeutics revenue & valuation

Annual revenue	$1,796,655
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,800,000
Total funding	$12,100,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

Re-Vana Therapeutics has 11 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Re-Vana Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-12-30	4	$12,100,000

Funding Insights

$12,100,000

Total funding amount

$12,100,000

Most recent funding amount

Number of funding rounds

Re-Vana Therapeutics Tech Stack

Discover the technologies and tools that power Re-Vana Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

Vimeo

Video players

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

DreamHost

Hosting

Google Analytics

Analytics

Frequently asked questions

Re-Vana Therapeutics is located in Belfast, N. Ireland, GB.

You can reach Re-Vana Therapeutics at +4420152024.

Re-Vana Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Re-Vana Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Re-Vana Therapeutics has raised a total of $12,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Re-Vana Therapeutics

Michael J. O'Rourke

Ceo

Brian Mccaul

Non Executive Director

Anna Sumeray

Director Board Of Directors

James Murray

Non Executive Director

Jenna Hewitt

Director Of Program Management

4.8